Literature DB >> 22855466

Apoptotic cell clearance and fibrotic lung disease.

William J Janssen, Konosuke Morimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22855466      PMCID： PMC4036233          DOI： 10.1183/09031936.00020612

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  13 in total

1.  Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice.

Authors:  K Morimoto; H Amano; F Sonoda; M Baba; M Senba; H Yoshimine; H Yamamoto; T Ii; K Oishi; T Nagatake
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

Review 2.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

3.  Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth.

Authors:  Heiko A Golpon; Valerie A Fadok; Laima Taraseviciene-Stewart; Robertas Scerbavicius; Clemens Sauer; Tobias Welte; Peter M Henson; Norbert F Voelkel
Journal:  FASEB J       Date:  2004-09-02       Impact factor: 5.191

4.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

Authors:  V A Fadok; D L Bratton; A Konowal; P W Freed; J Y Westcott; P M Henson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction.

Authors:  Ye-Ji Lee; Changsuk Moon; Seung Hae Lee; Hyun-Jeong Park; Ju-Young Seoh; Min-Sun Cho; Jihee Lee Kang
Journal:  Eur Respir J       Date:  2012-03-22       Impact factor: 16.671

6.  Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia.

Authors:  D Droemann; S P Aries; F Hansen; M Moellers; J Braun; H A Katus; K Dalhoff
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

7.  Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.

Authors:  J Yang; C Dai; Y Liu
Journal:  Gene Ther       Date:  2001-10       Impact factor: 5.250

8.  Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study.

Authors:  M Yaekashiwa; S Nakayama; K Ohnuma; T Sakai; T Abe; K Satoh; K Matsumoto; T Nakamura; T Takahashi; T Nukiwa
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

9.  Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Am J Physiol Renal Physiol       Date:  2003-09-30

10.  Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells.

Authors:  Xue Wang; Yushen Zhou; Hong Pyo Kim; Ruiping Song; Reza Zarnegar; Stefan W Ryter; Augustine M K Choi
Journal:  J Biol Chem       Date:  2003-11-18       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.